β1 integrin targeting to enhance radiation therapy

International Journal of Radiation Biology

Volumn 85, Issue 11, 2009, Pages 923-928

  Nam, Jin Min ^a   Chung, Yoonsun ^a,b   Hsu, Howard C ^a,b   Park, Catherine C ^a,b  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

1; Cancer; Integrin; Ionising radiation; Therapy

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ARGINYLGLYCYLASPARTIC ACID; BETA1 INTEGRIN; CILENGITIDE; N ACETYLPROLYLHISTIDYLSERYLCYSTEINYLASPARAGINE AMIDE; INTEGRIN;

ANTIANGIOGENIC ACTIVITY; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RESISTANCE; CELL TYPE; DRUG TARGETING; EXPERIMENTAL MODEL; EXTRACELLULAR MATRIX; HUMAN; IN VITRO STUDY; IN VIVO STUDY; IONIZING RADIATION; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RADIATION EXPOSURE; RADIOSENSITIVITY; SHORT SURVEY; ANIMAL; BIOLOGICAL MODEL; BREAST TUMOR; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; MOUSE; MULTIMODALITY CANCER THERAPY; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIATION DOSE; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD29; BREAST NEOPLASMS; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INTEGRINS; MICE; MODELS, BIOLOGICAL; NEOPLASMS; RADIATION TOLERANCE; SIGNAL TRANSDUCTION;

EID: 70449507354     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553000903232876     Document Type: Short Survey

References (44)

1. Abdollahi A, Griggs DW, Zieher H, Roth A, Lipson KE, Saffrich R, Grone HJ, Hallahan DE, Reisfeld RA, Debus J, Niethammer AG, Huber PE. 2005. Inhibition of alpha v beta 3integrin survival signaling enhances antiangiogenic and antitumor effects of radiotherapy. Clinical Cancer Research 11:6270-6279.
2. Albert JM, Cao C, Geng L, Leavitt L, Hallahan DE, Lu B. 2006. Integrin alpha v beta 3 antagonist Cilengitide enhances efficacy of radiotherapy in endothelial cell and non-small-cell lung cancer models. International Journal of Radiation Oncology Biology Physics 65:1536-1543.
3. Annabi B, Lee YT, Martel C, Pilorget A, Bahary JP, Beliveau R. 2003. Radiation induced-tubulogenesis in endothelial cells is antagonized by the antiangiogenic properties of green tea polyphenol (-) epigallocatechin-3- gallate. Cancer Biology and Therapy 2:642-649.
4. Bernier J, Hall EJ, Giaccia A. 2004. Radiation oncology: a century of achievements. Nature Reviews Cancer 4:737-747.
5. Briand P, Petersen OW, Van Deurs B. 1987. A new diploid nontumorigenic human breast epithelial cell line isolated and propagated in chemically defined medium. In vitro cellular and developmental biology 23:181-188.
6. Brown CK, Khodarev NN, Yu J, Moo-Young T, Labay E, Darga TE, Posner MC, Weichselbaum RR, Mauceri HJ. 2004. Glioblastoma cells block radiation-induced programmed cell death of endothelial cells. FEBS Letters 565:167-170.
7. Cance WG, Harris JE, Iacocca MV, Roche E, Yang X, Chang J, Simkins S, Xu L. 2000. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: Correlation with preinvasive and invasive phenotypes. Clinical Cancer Research 6:2417-2423.
8. Cao Q, Cai W, Li T, Yang Y, Chen K, Xing L, Chen X. 2006. Combination of integrin siRNA and irradiation for breast cancer therapy. Biochemical and Biophysical Research Communications 351:726-732.
9. Cordes N, Blaese MA, Meineke V, Van Beuningen D. 2002. Ionizing radiation induces up-regulation of functional beta1- integrin in human lung tumour cell lines in vitro. International Journal of Radiation Biology 78:347-357.
10. Cordes N, Frick S, Brunner TB, Pilarsky C, Grutzmann R, Sipos B, Kloppel G, McKenna WG, Bernhard EJ. 2007. Human pancreatic tumor cells are sensitized to ionizing radiation by knockdown of caveolin-1. Oncogene 26:6851-6862.
11. Cordes N, Hansmeier B, Beinke C, Meineke V, van Beuningen D. 2003. Irradiation differentially affects substratum-dependent survival, adhesion, and invasion of glioblastoma cell lines. British Journal of Cancer 89:2122-2132.
12. Cordes N, Park CC. 2007. Beta1 integrin as a molecular therapeutic target. International Journal of Radiation Biology 83:753-760.
13. Cordes N, Seidler J, Durzok R, Geinitz H, Brakebusch C. 2006. Beta1-integrin-mediated signaling essentially contributes to cell survival after radiation-induced genotoxic injury. Oncogene 25:1378-1390.
14. Damiano JS, Hazlehurst LA, Dalton WS. 2001. Cell adhesionmediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and gamma-irradiation. Leukemia 15:1232-1239.
15. Fujita S,Watanabe M, Kubota T, Teramoto T, KitajimaM. 1995. Alteration of expression in integrin beta 1-subunit correlates with invasion and metastasis in colorectal cancer. Cancer Letters 91:145-149.
16. Graff JR, Deddens JA, Konicek BW, Colligan BM, Hurst BM, Carter HW, Carter JH. 2001. Integrin-linked kinase expression increases with prostate tumor grade. Clinical Cancer Research 7:1987-1991.
17. Gruber G, Hess J, Stiefel C, Aebersold DM, Zimmer Y, Greiner RH, Studer U, Altermatt HJ, Hlushchuk R, Djonov V. 2005. Correlation between the tumoral expression of beta3-integrin and outcome in cervical cancer patients who had undergone radiotherapy. British Journal of Cancer 92:41-46.
18. Gudkov AV, Komarova EA. 2003. The role of p53 in determining sensitivity to radiotherapy. Nature Reviews Cancer 3:117-129.
19. Gupta AK, Cerniglia GJ, Mick R, Ahmed MS, Bakanauskas VJ, Muschel RJ, McKenna WG. 2003. Radiation sensitization of human cancer cells in vivo by inhibiting the activity of PI3K using LY294002. International Journal of Radiation Oncology Biology Physics 56:846-853.
20. Hynes RO. 2002. Integrins: Didirectional, allosteric signaling machines. Cell 110:673-687.
21. Johnson GE, Ivanov VN, Hei TK. 2008. Radiosensitization of melanoma cells through combined inhibition of protein regulators of cell survival. Apoptosis 13:790-802.
22. Kremer CL, Schmelz M, Cress AE. 2006. Integrin-dependent amplification of the G2 arrest induced by ionizing radiation. Prostate 66:88-96.
23. Lee GY, Kenny PA, Lee EH, BissellMJ. 2007. Three-dimensional culture models of normal and malignant breast epithelial cells. Nature Methods 4:359-365.
24. Meineke V, Gilbertz KP, Schilperoort K, Cordes N, Sendler A, Moede T, van Beuningen D. 2002. Ionizing radiation modulates cell surface integrin expression and adhesion of COLO-320 cells to collagen and fibronectin in vitro. Strahlentherapie und Onkologie 178:709-714.
25. Manning BD, Cantley LC. 2007. Akt/PKB signaling: Navigating downstream. Cell 129:1261-1274.
26. Ning S, Chen Z, Dirks A, Husbeck B, Hsu M, Bedogni B, O'Neill M, Powell MB, Knox SJ. 2007. Targeting integrins and PI3K/Akt-mediated signal transduction pathways enhances radiation-induced anti-angiogenesis. Radiation Research 168:125-133.
27. Ogata T, Teshima T, Kagawa K, Hishikawa Y, Takahashi Y, Kawaguchi A, Suzumoto Y, Nojima K, Furusawa Y, Matsuura N. 2005. Particle irradiation suppresses metastatic potential of cancer cells. Cancer Research 65:113-120.
28. Oktay MH, Oktay K, Hamele-Bena D, Buyuk A, Koss LG. 2003. Focal adhesion kinase as a marker of malignant phenotype in breast and cervical carcinomas. Human Pathology 34:240-245.
29. Onoda JM, Kantak SS, Piechocki MP, Awad W, Chea R, Liu B, Honn KV. 1994. Inhibition of radiation-enhanced expression of integrin and metastatic potential in B16 melanoma cells by a lipoxygenase inhibitor. Radiation Research 140:410-418.
30. Onoda JM, Piechocki MP, Honn KV. 1992. Radiation-induced increase in expression of the alpha IIb beta 3 integrin in melanoma cells: Effects on metastatic potential. Radiation Research 130:281-288.
31. Park CC, Henshall-Powell RL, Erickson AC, Talhouk R, Parvin B, Bissell MJ, Barcellos-Hoff MH. 2003. Ionizing radiation induces heritable disruption of epithelial cell interactions. Proceedings of the National Academy of Sciences of the United States of America 100:10728-10733.
32. Park CC, Mitsumori M, Nixon A, Recht A, Connolly J, Gelman R, Silver B, Hetelekidis S, Abner A, Harris JR, Schnitt SJ. 2000. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: Influence of margin status and systemic therapy on local recurrence. Journal of Clinical Oncology 18:1668-1675.
33. Park CC, Zhang H, Pallavicini M, Gray JW, Baehner F, Park CJ, Bissell MJ. 2006. Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo. Cancer Research 66:1526-1535.
34. Park CC, Zhang HJ, Yao ES, Park CJ, Bissell MJ. 2008. Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts. Cancer Research 68:4398-4405.
35. Pawar SC, Dougherty S, Pennington ME, Demetriou MC, Stea BD, Dorr RT, Cress AE. 2007. Alpha 6 integrin cleavage: sensitizing human prostate cancer to ionizing radiation. International Journal of Radiation Biology 83:761-767.
36. Sandfort V, Koch U, Cordes N. 2007. Cell adhesion-mediated radioresistance revisited. International Journal of Radiation Biology 83:727-732.
37. Schmeichel KL, Bissell MJ. 2003. Modeling tissue-specific signaling and organ function in three dimensions. Journal of Cell Science 116:2377-2388.
38. Simon EL, Goel HL, Teider N, Wang T, Languino LR, Fitzgerald TJ. 2005. High dose fractionated ionizing radiation inhibits prostate cancer cell adhesion and beta1 integrin expression. Prostate 64:83-91.
39. Smith RA, Giorgio TD. 2004. Quantitation and kinetics of CD51 surface receptor expression: Implications for targeted delivery. Annals of Biomedical Engineering 32: 635-644.
40. Wang F, Weaver VM, Petersen OW, Larabell CA, Dedhar S, Briand P, Lupu R, Bissell MJ. 1998. Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proceedings of the National Academy of Sciences of the United States of America 95:14821-14826.
41. Weaver VM, Fischer AH, Peterson OW, Bissell MJ. 1996. The importance of the microenvironment in breast cancer progression: Recapitulation of mammary tumorigenesis using a unique human mammary epithelial cell model and a threedimensional culture assay. Biochemistry and Cell Biology 74:833-851.
42. White DE, Kurpios NA, Zuo D, Hassell JA, Blaess S, Mueller U, Muller WJ. 2004. Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell 6:159-170.
43. Wild-Bode C, Weller M, Rimner A, Dichgans J, Wick W. 2001. Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Research 61:2744-2750.
44. Yao ES, Zhang H, Chen YY, Lee B, Chew K, Moore D, Park C. 2007. Increased beta1 integrin is associated with decreased survival in invasive breast cancer. Cancer Research 67:659-664.